These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 11247187)

  • 21. Effects of methylprednisolone and glatiramer acetate on nitric oxide formation of cytokine-stimulated cells from the rat oligodendroglial cell line OLN-93.
    Holzknecht C; Röhl C
    Neuroimmunomodulation; 2010; 17(1):23-30. PubMed ID: 19816054
    [TBL] [Abstract][Full Text] [Related]  

  • 22. IL-2 activation of STAT5 enhances production of IL-10 from human cytotoxic regulatory T cells, HOZOT.
    Tsuji-Takayama K; Suzuki M; Yamamoto M; Harashima A; Okochi A; Otani T; Inoue T; Sugimoto A; Motoda R; Yamasaki F; Nakamura S; Kibata M
    Exp Hematol; 2008 Feb; 36(2):181-92. PubMed ID: 18023521
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Defective production of anti-inflammatory cytokine, TGF-beta by T cell lines of patients with active multiple sclerosis.
    Mokhtarian F; Shi Y; Shirazian D; Morgante L; Miller A; Grob D
    J Immunol; 1994 Jun; 152(12):6003-10. PubMed ID: 8207225
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cytokines in the pathogenesis of multiple sclerosis.
    Carrieri PB; Maiorino A; Provitera V; Soscia E; Perrella O
    Acta Neurol (Napoli); 1992; 14(4-6):333-41. PubMed ID: 1293976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Neurotransmission mechanism of movement disorders in multiple sclerosis].
    Barkhatova VP; Panteleeva EA; Alferova VP; Rebrova OIu; Niiazbekova AS; Zavalishin IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(2):43-8. PubMed ID: 18379521
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immune-mediated oligodendrocyte injury in multiple sclerosis: molecular mechanisms and therapeutic interventions.
    Buntinx M; Stinissen P; Steels P; Ameloot M; Raus J
    Crit Rev Immunol; 2002; 22(5-6):391-424. PubMed ID: 12803318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-gamma, interleukin-4 and transforming growth factor-beta mRNA expression in multiple sclerosis and myasthenia gravis.
    Link J
    Acta Neurol Scand Suppl; 1994; 158():1-58. PubMed ID: 7732782
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific central nervous system recruitment of HLA-G(+) regulatory T cells in multiple sclerosis.
    Huang YH; Zozulya AL; Weidenfeller C; Metz I; Buck D; Toyka KV; Brück W; Wiendl H
    Ann Neurol; 2009 Aug; 66(2):171-83. PubMed ID: 19705413
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Somatostatin preserved blood brain barrier against cytokine induced alterations: possible role in multiple sclerosis.
    Basivireddy J; Somvanshi RK; Romero IA; Weksler BB; Couraud PO; Oger J; Kumar U
    Biochem Pharmacol; 2013 Aug; 86(4):497-507. PubMed ID: 23770458
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumour necrosis factor-alpha synthesis by cerebrospinal-fluid-derived T cell clones from patients with multiple sclerosis.
    Buttinelli C; Toma L; Falcone MM; Salvetti M; Ristori G; Barnaba V; Fieschi C
    Ital J Neurol Sci; 1992 Dec; 13(9 Suppl 14):79-83. PubMed ID: 1345744
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytokine-induced enhancement of autoimmune inflammation in the brain and spinal cord: implications for multiple sclerosis.
    Sun D; Newman TA; Perry VH; Weller RO
    Neuropathol Appl Neurobiol; 2004 Aug; 30(4):374-84. PubMed ID: 15305983
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS?
    Bar-Or A; Fawaz L; Fan B; Darlington PJ; Rieger A; Ghorayeb C; Calabresi PA; Waubant E; Hauser SL; Zhang J; Smith CH
    Ann Neurol; 2010 Apr; 67(4):452-61. PubMed ID: 20437580
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pathogenesis of myelin/oligodendrocyte damage in multiple sclerosis.
    Dhib-Jalbut S
    Neurology; 2007 May; 68(22 Suppl 3):S13-21; discussion S43-54. PubMed ID: 17548563
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon beta promotes nerve growth factor secretion early in the course of multiple sclerosis.
    Biernacki K; Antel JP; Blain M; Narayanan S; Arnold DL; Prat A
    Arch Neurol; 2005 Apr; 62(4):563-8. PubMed ID: 15824253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cytotoxic NKG2C+ CD4 T cells target oligodendrocytes in multiple sclerosis.
    Zaguia F; Saikali P; Ludwin S; Newcombe J; Beauseigle D; McCrea E; Duquette P; Prat A; Antel JP; Arbour N
    J Immunol; 2013 Mar; 190(6):2510-8. PubMed ID: 23396942
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Disturbed regulatory T cell homeostasis in multiple sclerosis.
    Venken K; Hellings N; Liblau R; Stinissen P
    Trends Mol Med; 2010 Feb; 16(2):58-68. PubMed ID: 20159585
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Decrease of suppressor inducer (CD4+2H4+) T cells in multiple sclerosis cerebrospinal fluid.
    Chofflon M; Weiner HL; Morimoto C; Hafler DA
    Ann Neurol; 1989 May; 25(5):494-9. PubMed ID: 2528316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glatiramer acetate-specific T cells in the brain express T helper 2/3 cytokines and brain-derived neurotrophic factor in situ.
    Aharoni R; Kayhan B; Eilam R; Sela M; Arnon R
    Proc Natl Acad Sci U S A; 2003 Nov; 100(24):14157-62. PubMed ID: 14614135
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-term treatment of relapsing remitting multiple sclerosis patients with interferon (IFN)-beta1B transiently increases the blood levels of interleukin (IL)-6, IL-10 and IFN-gamma without significantly modifying those of IL-1beta, IL-2, IL-4 and tumour necrosis factor-alpha.
    Nicoletti F; Di Marco R; Patti F; Zaccone P; L'Episcopo MR; Reggio E; Xiang M; Nicoletti A; Reggio A
    Cytokine; 2000 Jun; 12(6):682-7. PubMed ID: 10843745
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bio-markers of disease activity and response to therapy in multiple sclerosis.
    Miller A; Glass-Marmor L; Abraham M; Grossman I; Shapiro S; Galboiz Y
    Clin Neurol Neurosurg; 2004 Jun; 106(3):249-54. PubMed ID: 15177778
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.